Dr. Leen's research interests involve using cytotoxic T cells (CTL) for viral and malignant diseases. Dr. Leen is a co-principal investigator on a clinical trial assessing the safety of adoptively transferred donor-derived virus-specific CTL for the prophylaxis and treatment of adenoviral infections post allogeneic stem cell transplant. She is also developing and optimizing methods for generating tumor-specific CTL directed against the cancer testis antigens SSX2 and SSX4, which are expressed in a variety of tumors including Hodgkin Reed Sternberg cells. Therefore, the development of effective methods to reactivate and expand tumor-specific T cells directed against these antigens will lead to the development of immunotherapy protocols for the treatment of patients with relapsed EBV negative Hodgkin's disease and non-Hodgkin Lymphoma.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
Gulf Coast Consortia Immunology Cluster
Training Grants
The Cancer Therapeutics Training Program (CTTP)
Appointments
Title
Department / School
Institution
Professor
Pediatrics, Hematology-Oncology, Center for Cell and Gene Therapy
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.